Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Repaglinide
Cat. No.:
0225LY-0878
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Repaglinide is a benzoic acid derivative used to stimulate pancreatic insulin secretion in type 2 diabetes patients, though it has been associated with rare instances of liver injury.
Synonym:
135062-02-1; Prandin; Repaglinidum; Repaglinida; (S)-2-Ethoxy-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid; Surepost; Reglin; 2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid; MFCD00906179; (+)-2-Ethoxy-alpha-(((S)-alpha-isobutyl-o-piperidinobenzyl)carbamoyl)-p-toluic acid; (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid; (S)-2-ethoxy-4-(2-(3-methyl-1-(2-(piperidin-1-yl)phenyl)butylamino)-2-oxoethyl)benzoic acid; =2-Ethoxy-4-{[(S)-3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid; Benzoic Acid, 2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)-,(S)-
CAS No.:
135062-02-1
Compound CID:
65981
Formula:
C27H36N2O4
Formula Weight:
452.59
Specification
Relative Density:
1.137 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Repaglinide can be used in diabetes research to study the stimulation of prandial insulin release from pancreatic beta cells.
Library Information
Target:
PPAR; Potassium channel
Receptor:
Potassium channel; PPARγ
Pathways:
Metabolism; DNA damage/DNA repair; Membrane transporter/Ion channel
Plate Number:
AOCL-12
Plate Location:
c7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
250 mg/mL; 552.38 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
84 mg/mL; 185.6 mM
ALogP:
5.307
HBA_Count:
3
HBD_Count:
1
Rotatable Bond:
10
